Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT